NCT03569527

Brief Summary

This is a parallel group pilot study comparing the efficacy green kiwifruit, prunes or psyllium on abdominal and bowel related symptoms in US patients with chronic constipation patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

June 11, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 26, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2019

Completed
Last Updated

October 17, 2019

Status Verified

October 1, 2019

Enrollment Period

1.3 years

First QC Date

June 11, 2018

Last Update Submit

October 16, 2019

Conditions

Keywords

Kiwifruit

Outcome Measures

Primary Outcomes (1)

  • : Change in complete spontaneous bowel movement (CSBM)

    Complete spontaneous bowel movement will be recorded. This will be compared to the baseline, run-in periods, and follow-up period.

    8 weeks

Secondary Outcomes (6)

  • Change in SBM (spontaneous bowel movements)

    8 weeks

  • stool consistency

    8 weeks

  • straining

    8 weeks

  • abdominal pain

    8 weeks

  • abdominal discomfort

    8 weeks

  • +1 more secondary outcomes

Study Arms (3)

Kiwifruit

ACTIVE COMPARATOR

Treating chronic constipation with 2 kiwifruit (6g fiber) per day

Dietary Supplement: Kiwifruit

Psyllium fiber

ACTIVE COMPARATOR

Treating chronic constipation with 24g psyllium fiber (6g fiber) per day

Dietary Supplement: Fiber

Prune

ACTIVE COMPARATOR

Treating chronic constipation with 100g dried plums (6g fiber) per day

Dietary Supplement: Prunes

Interventions

KiwifruitDIETARY_SUPPLEMENT

The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive kiwifruit (2 green kiwifruit per day for the 4 week intervention period.

Kiwifruit
FiberDIETARY_SUPPLEMENT

The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive psyllium fiber (24 g/day, fiber=6g/day) for the 4 week intervention period.

Psyllium fiber
PrunesDIETARY_SUPPLEMENT

The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive prunes/dried plums (100g, fiber=6 g/day) for the 4 week intervention period.

Also known as: Dried Plums
Prune

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Presence of functional constipation according to modified ROME IV diagnostic criteria\*5b i. Must include two or more of the following:
  • Straining more than 25% of defecations
  • Lumpy or hard stools more than 25% of defecations
  • Sensation of incomplete evacuation more than 25% of defecations
  • Sensation of anorectal obstruction/blockage more than 25% of defecations
  • Manual manoeuvres to facilitate more than 25% of defecations (e.g. digital evacuation, support of pelvic floor)
  • Fewer than three defecations per week ii. Loose stools are rarely present without the use of laxatives \* Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis For the purposes of this study, patients with abdominal pain will be included, but patients with severe pain (defined as average daily abdominal pain score of 7 or higher during the screening period) will be excluded. Patients with an appropriate level of GI symptoms despite taking stable doses (\>3 months) of SSRI's, tricyclics or SNRIs will be allowed to enroll.

You may not qualify if:

  • Potential participants will be excluded if they have alarm features (GI bleeding, weight loss, unexplained iron deficiency anaemia, significant family history of colorectal cancer or IBD), anal fissures, significant chronic diseases (cardiovascular, cancer, renal failure, inflammatory bowel disease), previous gastrointestinal surgery (except appendectomy or cholecystectomy), neurological diseases (e.g. multiple sclerosis, spinal cord injury, CVA).
  • Patients taking opiates will not be eligible to participate. Women who are pregnant, breastfeeding or planning a pregnancy in the 2 months post selection (trial period) will be excluded.
  • As above, patients with severe IBS symptoms will be excluded (defined as average daily abdominal pain score of 7 or higher during the screening period).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Related Publications (2)

  • Chey SW, Chey WD, Jackson K, Eswaran S. Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation. Am J Gastroenterol. 2021 Jun 1;116(6):1304-1312. doi: 10.14309/ajg.0000000000001149.

  • Dimidi E, Staudacher HM. Could a kiwifruit a day keep the doctor away? Lancet Gastroenterol Hepatol. 2020 Jul;5(7):648. doi: 10.1016/S2468-1253(20)30163-1. No abstract available.

MeSH Terms

Interventions

alcohol acyltransferase, ActinidiaDietary Fiber

Intervention Hierarchy (Ancestors)

Dietary CarbohydratesCarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Shanti Eswaran, MD

    Department of Internal Medicine, Division of Gastroenterology, University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

June 11, 2018

First Posted

June 26, 2018

Study Start

June 11, 2018

Primary Completion

October 10, 2019

Study Completion

October 10, 2019

Last Updated

October 17, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations